David Happel - 16 Nov 2023 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
President & CEO, Director
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
Issuer symbol
SGMT
Transactions as of
16 Nov 2023
Net transactions value
+$1,386
Form type
4
Filing time
20 Nov 2023, 21:59:29 UTC
Previous filing
20 Jul 2023
Next filing
21 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGMT Series A Common Stock Purchase $1,386 +590 $2.35 590 16 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.31 per share to $2.40 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each price.